218 related articles for article (PubMed ID: 23388185)
1. Progressive decrease in amplitude of intracardiac ventricular electrogram and higher left ventricular ejection fraction are associated with conductors' externalization in Riata leads.
Kubala M; Traullé S; Leborgne L; Hermida JS
Europace; 2013 Aug; 15(8):1198-204. PubMed ID: 23388185
[TBL] [Abstract][Full Text] [Related]
2. Fluoroscopic and electrical assessment of a series of defibrillation leads: prevalence of externalized conductors.
Kodoth VN; Hodkinson EC; Noad RL; Ashfield KP; Cromie NA; McEneaney DJ; Wilson CM; Roberts MJ
Pacing Clin Electrophysiol; 2012 Dec; 35(12):1498-504. PubMed ID: 23035735
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and presentation of externalized conductors and electrical abnormalities in Riata defibrillator leads after fluoroscopic screening: report from the Netherlands Heart Rhythm Association Device Advisory Committee.
Theuns DA; Elvan A; de Voogt W; de Cock CC; van Erven L; Meine M
Circ Arrhythm Electrophysiol; 2012 Dec; 5(6):1059-63. PubMed ID: 23091049
[TBL] [Abstract][Full Text] [Related]
4. Mechanical and electrical dysfunction of Riata implantable cardioverter-defibrillator leads.
Demirel F; Adiyaman A; Delnoy PP; Smit JJ; Ramdat Misier AR; Elvan A
Europace; 2014 Dec; 16(12):1787-94. PubMed ID: 24843049
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of insulation failure with externalized cables in St. Jude Medical Riata family ICD leads: fluoroscopic grading scale and correlation to extracted leads.
Parvathaneni SV; Ellis CR; Rottman JN
Heart Rhythm; 2012 Aug; 9(8):1218-24. PubMed ID: 22449742
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of externalized conductors in Riata and Riata ST silicone leads: results from the prospective, multicenter Riata Lead Evaluation Study.
Hayes D; Freedman R; Curtis AB; Niebauer M; Neal Kay G; Dinerman J; Beau S
Heart Rhythm; 2013 Dec; 10(12):1778-82. PubMed ID: 23994078
[TBL] [Abstract][Full Text] [Related]
7. Conductor externalization of the Riata internal cardioverter defibrillator lead: tip of the iceberg? Report of three cases and review of literature.
Dorman HG; van Opstal JM; Stevenhagen J; Scholten MF
Europace; 2012 Aug; 14(8):1161-4. PubMed ID: 22431444
[TBL] [Abstract][Full Text] [Related]
8. Fluoroscopic screening of asymptomatic patients implanted with the recalled Riata lead family.
Liu J; Rattan R; Adelstein E; Barrington W; Bazaz R; Brode S; Jain S; Mendenhall GS; Nemec J; Razak E; Shalaby A; Schwartzman D; Voigt A; Wang NC; Saba S
Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):809-14. PubMed ID: 22787015
[TBL] [Abstract][Full Text] [Related]
9. Riata implantable cardioverter-defibrillator lead failure: analysis of explanted leads with a unique insulation defect.
Hauser RG; McGriff D; Retel LK
Heart Rhythm; 2012 May; 9(5):742-9. PubMed ID: 22209723
[TBL] [Abstract][Full Text] [Related]
10. Lead thrombi associated with externalized cables on Riata ICD leads: a case series.
Goyal SK; Ellis CR; Rottman JN; Whalen SP
J Cardiovasc Electrophysiol; 2013 Sep; 24(9):1047-50. PubMed ID: 23577693
[TBL] [Abstract][Full Text] [Related]
11. The Canadian experience with Durata and Riata ST Optim defibrillator leads: a report from the Canadian Heart Rhythm Society Device Committee.
Bennett MT; Ha AC; Exner DV; Tung SK; Parkash R; Connors S; Coutu B; Crystal E; Champagne J; Philippon F; Yee R; Stephenson EA; Nery PB; Essebag V; Sanatani S; Redfearn D; Krahn AD; Healey JS
Heart Rhythm; 2013 Oct; 10(10):1478-81. PubMed ID: 23973950
[TBL] [Abstract][Full Text] [Related]
12. Fluoroscopic investigation of Riata® transvenous defibrillator leads.
Singh G; Lahiri MK; Khan A; Fang KD; Schuger CD
Cardiol J; 2015; 22(1):57-67. PubMed ID: 24846515
[TBL] [Abstract][Full Text] [Related]
13. Prospective nationwide fluoroscopic and electrical longitudinal follow-up of recalled Riata defibrillator leads in Denmark.
Larsen JM; Nielsen JC; Johansen JB; Haarbo J; Petersen HH; Thøgersen AM; Hjortshøj SP
Heart Rhythm; 2014 Dec; 11(12):2141-7. PubMed ID: 25008285
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of asymptomatic and electrically undetectable intracardiac inside-out abrasion in silicon-coated Riata® and Riata® ST implantable cardioverter-defibrillator leads.
Schmutz M; Delacrétaz E; Schwick N; Roten L; Fuhrer J; Boesch C; Tanner H
Int J Cardiol; 2013 Jul; 167(1):254-7. PubMed ID: 22236515
[TBL] [Abstract][Full Text] [Related]
15. Insight into the mechanism of failure of the Riata lead under advisory.
Parkash R; Tung S; Champagne J; Healey JS; Thibault B; Cameron D; Tang A; Connors S; Beardsall M; Mangat I; Ayala-Paredes F; Toal S; Exner D; Yee R; Krahn AD
Heart Rhythm; 2015 Mar; 12(3):574-579. PubMed ID: 25485777
[TBL] [Abstract][Full Text] [Related]
16. What did we learn from Riata™?
Fischer A; Jenney C
Herzschrittmacherther Elektrophysiol; 2015 Jun; 26(2):105-10. PubMed ID: 26054484
[TBL] [Abstract][Full Text] [Related]
17. Prospective long-term evaluation of Optim-insulated (Riata ST Optim and Durata) implantable cardioverter-defibrillator leads.
Cairns JA; Epstein AE; Rickard J; Connolly SJ; Buller C; Wilkoff BL; Pogue J; Themeles E; Healey JS
Heart Rhythm; 2014 Dec; 11(12):2156-62. PubMed ID: 25131665
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal follow-up of externalized Riata leads.
Liu J; Qin D; Rattan R; Bazaz R; Adelstein E; Jain S; Saba S
Am J Cardiol; 2013 Nov; 112(10):1616-8. PubMed ID: 24012025
[TBL] [Abstract][Full Text] [Related]
19. Externalized conductors and electrical dysfunction in transvenous ventricular leads: Results of the Cardiac Lead Assessment Study.
Freedman RA; Curtis AB; Delgado SM; Lee LY
Heart Rhythm O2; 2022 Apr; 3(2):160-168. PubMed ID: 35496462
[TBL] [Abstract][Full Text] [Related]
20. Safe extraction of Riata looped extruding filler cables.
Rubenstein DS; Weston LT; Kneller J; Wright C; Yin H
J Cardiovasc Electrophysiol; 2013 Aug; 24(8):942-6. PubMed ID: 23837462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
